FN2 Earnings Intelligence
Northrop Grumman Corporation earnings overview
Latest Northrop Grumman Corporation (NOC) earnings intelligence, including the newest scorecard, market reaction, and transcript analysis.
Northrop Grumman Corporation
Northrop Grumman’s latest call supports a constructive operating thesis: demand, backlog and program ramps provide visible growth drivers, while higher investment and execution requirements temper the outlook.
Northrop Grumman Corporation
Northrop Grumman delivered a strong Q2 2026, beating consensus on both EPS and revenue while building a record $105 billion backlog on $20 billion in new awards. Management raised full-year sales guidance to $44 billion and lifted EPS guidance by $1.20, driven by accelerating demand across B-21, Sentinel, missile defense, and international programs. The stock initially fell 3.1% on the day despite the beat, likely reflecting margin pressure from EAC adjustments on GEM 63XL and Stand-in Attack Weapon, but subsequently recovered with a 7.2% drift over the following sessions. The central question is whether H2 margin improvement materializes as management expects, and whether elevated capex will sustain the growth trajectory without pressuring free cash flow.
Northrop Grumman Corporation
Northrop Grumman's case rests on a record ~$96 billion backlog providing more than two years of sales coverage, plus durable tailwinds from rising global defense budgets and triad modernization. Management is choosing to invest that position, raising 2026 capex to ~$1.85 billion to accelerate B-21 production and expand solid-rocket-motor capacity, accepting near-term free-cash-flow pressure in exchange for potential margin upside later in the decade. The modest EPS and revenue beats and reaffirmed guidance support the backdrop, though the sharp post-print share decline and concerns over capex versus free cash flow temper the near-term picture.
Northrop Grumman Corporation
Northrop Grumman's record backlog and maintained 2026 outlook support a constructive operating thesis, but conversion depends on program timing, capacity execution and defense funding.
Northrop Grumman Corporation
The supplied analysis supports a mixed but constructive operating thesis: defense demand, international modernization, and program expansion provide growth support, while delayed awards, high capex, and execution risks temper the outlook.
Northrop Grumman Corporation
The current analysis supports a constructive near-term operating thesis: strong Q2 execution, raised guidance, international growth, and defense-program demand strengthen the outlook, while taxes, capital intensity, and large-program execution remain material offsets.
Northrop Grumman Corporation
The supplied analysis supports a mixed but constructive operating picture: resilient defense demand and international activity support the growth case, while B-21 execution, margins, cost pressure and contract timing remain material tests.
Northrop Grumman Corporation
The supplied analysis supports a constructive demand and growth backdrop for Northrop Grumman, led by backlog, international programs, and B-21/IBCS activity. The case remains dependent on disciplined execution, program schedules, margin delivery, and the returns from higher capex.
Get the NOC recap when the next report posts
One email per quarter with the scorecard, the market reaction and what changed on the call. No account needed.